Bladder cancer affects more than 86,000 people in the United States each year, according to the American Cancer Society, with the majority being over age 55. And while the disease can often be ...
The University of Washington in Seattle is using a blue light cystoscopy that makes tumors glow a bright pink color, allowing surgeons to better identify non-muscle-invasive bladder cancer. “Seventy ...
In the last couple of years, Professor Syed Hussain has become increasingly concerned by the growing number of patients presenting with bladder cancer at an advanced stage. “Since Covid, there has ...
The U.S. Food and Drug Administration has approved Adstiladrin, which is being billed as the first gene therapy treating high-risk, non-muscle-invasive bladder cancer. Adstiladrin is a non-replicating ...
Medical professionals use CT scans to help diagnose and stage bladder cancer. While CT scans can provide valuable information, they are not perfect and have certain limitations. However, CT scans may ...
(StatePoint) When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life patients.) ...
When a patient is diagnosed with bladder cancer, their first question is often “Will I be able to keep my bladder?” When bladder cancer is caught early, it’s not always necessary to remove the whole ...
EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ Endoscopy-America, Inc., a leader in endoscopy and related technology solutions, announced its system for performing Blue Light Cystoscopy with Cysview® ...
(StatePoint) The bladder cancer treatment landscape is rapidly evolving, particularly for patients who don’t respond to bacillus Calmette–Guérin (BCG), the most common intravesical immunotherapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback